Evidence map›Paper›PMID 40430482›Full record

ArticlePharmaceuticals (Basel, Switzerland)2025

Norfloxacin Derivative with Carbazole at C-7 FQB-1 Induces Cytotoxic, Antiproliferative, and Antitumor Effects in an Experimental Lung Carcinoma Model.

Alondra Bocanegra-Zapata, Hiram Hernández-López, Socorro Leyva-Ramos, Rodolfo Daniel Cervantes-Villagrana, Marisol Galván-Valencia, L Angel Veyna-Hurtado, Norma Guadalupe Ramírez Tovar, Damaris Albores-García, Juan Armando Flores de la Torre, Alberto Rafael Cervantes-Villagrana

Abstract read
In one paragraph

Article in Pharmaceuticals (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Alondra Bocanegra-ZapataMaestría en Ciencia y Tecnología Química, Unidad Académica de Ciencias Químicas, Universidad Autónoma de Zacatecas, Zacatecas 98160, Mexico.ORCID 0009-0009-1612-6322
Hiram Hernández-LópezLaboratorio de Investigación en Síntesis y Modificación Química, Unidad Académica de Ciencias Químicas, Universidad Autónoma de Zacatecas, Zacatecas 98160, Mexico.ORCID 0000-0002-4286-163X
Socorro Leyva-RamosLaboratorio de Investigación en Síntesis Orgánica, Facultad de Ciencias Químicas, Universidad Autónoma de San Luis Potosí, San Luis Postosí 78210, Mexico.ORCID 0000-0001-6303-3107
Rodolfo Daniel Cervantes-VillagranaMoores Cancer Center, University of California San Diego, La Jolla, CA 92093, USA.ORCID 0000-0002-6599-7994
Marisol Galván-ValenciaLaboratorio de Neuropatología y Productos Naturales, Unidad Académica de Ciencias Químicas, Universidad Autónoma de Zacatecas, Zacatecas 98050, Mexico.ORCID 0000-0002-3640-5443
L Angel Veyna-HurtadoLaboratorio de Investigación en Terapéutica Experimental, Unidad Académica de Ciencias Químicas, Universidad Autónoma de Zacatecas, Zacatecas 98160, Mexico.ORCID 0000-0003-0002-4419
Norma Guadalupe Ramírez TovarLaboratorio de Investigación en Terapéutica Experimental, Unidad Académica de Ciencias Químicas, Universidad Autónoma de Zacatecas, Zacatecas 98160, Mexico.ORCID 0009-0002-8766-2607
Damaris Albores-GarcíaDepartamento de Farmacobiología, Centro de Investigación y de Estudios Avanzados del Instituto Politécnico Nacional (Cinvestav), Unidad Sede Sur, Mexico City 14330, Mexico.ORCID 0000-0003-3437-4791
Juan Armando Flores de la TorreLaboratorio de Investigación en Toxicología y Farmacia, Unidad Académica de Ciencias Químicas, Universidad Autónoma de Zacatecas, Zacatecas 98160, Mexico.ORCID 0000-0002-4660-5641
Alberto Rafael Cervantes-VillagranaLaboratorio de Investigación en Terapéutica Experimental, Unidad Académica de Ciencias Químicas, Universidad Autónoma de Zacatecas, Zacatecas 98160, Mexico.ORCID 0000-0001-7344-353X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

antineoplasticcytotoxicfluoroquinolonelung cancermolecular docking

Identifiers

PMID40430482
PMCPMC12114400

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.